MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61.
Oncogene
Zarei, Mahsa M; Giannikou, Krinio K; Du, Heng H; Liu, Heng-Jia HJ; Duarte, Melissa M; Johnson, Sneha S; Nassar, Amin H AH; Widlund, Hans R HR; Henske, Elizabeth P EP; Long, Henry W HW; Kwiatkowski, David J DJ
Publication Date: 2021-01
Variant appearance in text: TSC2: 5238delC; H1746Qfs*80